Company · CIK 0001540159 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Edesa Biotech, Inc. · EDSA
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 AForm 4 → | Sep 1, 6:12 pm EDT | Pardeep NijhawanChief Executive Officer, Director, 10% Owner | 5,714 | — | — | 899,100 | — | |
| Aug 3, 2026 AForm 4 → | Aug 4, 5:02 pm EDT | Pardeep NijhawanChief Executive Officer, Director, 10% Owner | 5,324 | — | — | 893,386 | — | |
| Jul 2, 2026 AForm 4 → | Jul 2, 5:05 pm EDT | Pardeep NijhawanChief Executive Officer, Director, 10% Owner | 3,378 | — | — | 888,062 | — | |
| Jun 16, 2026 AForm 4 → | Jun 16, 5:03 pm EDT | Pardeep NijhawanChief Executive Officer, Director, 10% Owner | 153,550 | $5.21 | $799,996 | 884,684 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.